Inactive Instrument

News SpectraCure AB (publ) Nasdaq Stockholm

Equities

SE0007158118

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

SpectraCure takes the next step in the work with the new clinical study	02-23	AQ
Spectracure AB Continues in the Process of Initiating A Clinical Study, for Primary Localised Prostate Cancer	02-23	CI
SpectraCure AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	02-22	CI
A well-accomplished annual audit in accordance with ISO 13485:2016	01-23	AQ
Expert group comments on results of ongoing study	12-19	AQ
SpectraCure AB Conducts a Clinical Study for Patients with Recurrence of Prostate Cancer After Radiotherapy	12-19	CI
SpectraCure : Masoud Khayyami presents SpectraCure at investor meetingon November 5 in Lund!	11-29	PU
SpectraCure AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-16	CI
SpectraCure has decided to seek approval for a clinical study of primary prostate cancer	11-16	AQ
SpectraCure AB Decides to Seek Approval for Clinical Study of Primary Prostate Cancer	11-16	CI
SpectraCure : Meet SpectraCure’s board member, Homer Pien!	31/10/23	PU
SpectraCure strengthens presence among urologists	06/10/23	AQ
SpectraCure AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	17/08/23	CI
SpectraCure has been awarded an additional EU grant for industrialisation of the company's treatment system Q-PRO®	27/06/23	AQ
SpectraCure Receives an Additional EU Grant	27/06/23	CI
SpectraCure AB Reports Earnings Results for the First Quarter Ended March 31, 2023	16/05/23	CI
SpectraCure AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	22/02/23	CI
SpectraCures signs Letter of Intent with Cheplapharm	07/12/22	AQ
SpectraCures Signs Letter of Intent with Cheplapharm	07/12/22	CI
SpectraCure : First treatment with Q-PRO and integrated image management technology	24/11/22	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News SpectraCure AB (publ) Nasdaq Stockholm

Equities

SE0007158118

Summary

Filters